DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP 100 MCG — DIN 02537095
DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) : 100 MCG · HIKMA CANADA LIMITED · SOLUTION · wholesale supply in Canada
Health Canada status: APPROVED
What is DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP?
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP 100 MCG contains DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) : 100 MCG. It is listed in the Health Canada Drug Product Database under DIN 02537095, held by HIKMA CANADA LIMITED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as approved, status dated 05-Apr-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Dexmedetomidine cost around the world?
Dexmedetomidine is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory); Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 8 | 13 | SAR███.██ |
| Greece | producer price (ex-factory) | 8 | 8 | EUR███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| South Africa | single exit price | 3 | 3 | ZAR███.██ |
| Bahrain | retail (max) | 1 | 1 | BHD███.██ |
32 pack listings across 27 brand entries and 5 price bases, refreshed 03 Sep 2026. Ranges span every Dexmedetomidine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Dexmedetomidine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Dexmedetomidine, across 16 DINs, of which 9 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| JUNO PHARMACEUTICALS CORP. | 3 | 3 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP, DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| HIKMA CANADA LIMITED | 2 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP, DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| PFIZER CANADA ULC | 2 | 1 | PRECEDEX | Sourceable in Canada |
| ACCORD HEALTHCARE INC | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Sourceable in Canada |
| AURO PHARMA INC | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Sourceable in Canada |
| BAXTER CORPORATION | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | Sourceable in Canada |
| EUGIA PHARMA INC. | 1 | 1 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | Sourceable in Canada |
| OMEGA LABORATORIES LIMITED | 3 | 0 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP, DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | No marketed DIN |
| FRESENIUS KABI CANADA LTD | 1 | 0 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 1 | 0 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MCG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Dexmedetomidine |
|---|---|
| ATC code | N05CM18 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02537095 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2537095 |
| Brand name | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP |
| Generic / active ingredient | DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) : 100 MCG |
| Market authorization holder | HIKMA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | N05CM18 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05CM |
| Current status | APPROVED |
| Status date | 05-Apr-2023 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Dexmedetomidine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by HIKMA CANADA LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
9 of 16 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | EUGIA PHARMA INC. | MARKETED | 02528886 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | AURO PHARMA INC | MARKETED | 02464381 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED | 02477327 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | 100 MCG | SOLUTION | BAXTER CORPORATION | MARKETED | 02513978 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | 100 MCG | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02467976 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | 4 MCG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02537109 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | 200 MCG / 50 ML | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02487365 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | 400 MCG / 100 ML | SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02487373 |
| PRECEDEX | 4 MCG | SOLUTION | PFIZER CANADA ULC | MARKETED | 02437147 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | 100 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | 02493314 |
2 · Same class — other molecules in ATC N05CM
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Dexmedetomidine | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION · DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP · DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP · DEXMEDETOMIDINE HYDROCHLORIDE INJECTION · +1 more | 16 | 9 | Yes |
| Scopolamine | SCOPOLAMINE HYDROBROMIDE INJECTION | 2 | 2 | Yes |
| Valerianae Radix | ARTRYL CAP 200 MG · EFFIDOSE VALERIANE LIQ 1916MG/10ML AMP · ETHICAL HERBALS SLEEP AID · FACILITE LE SOMMEIL - CAP 270MG · +6 more | 10 | 0 | Not in Canada |
| Ethchlorvynol | PLACIDYL CAP 200MG · PLACIDYL CAP 500MG · PLACIDYL CAP 750MG | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05CF | Eszopiclone · Zaleplon · Zolpidem · Zopiclone | 125 | 57 |
| N05CD | Estazolam · Flurazepam · Midazolam · Nitrazepam · Temazepam · +1 more | 108 | 21 |
| N05CC | Chloral Hydrate · Paraldehyde | 9 | 1 |
| N05CJ | Daridorexant · Suvorexant | 6 | 1 |
| N05CA | Amobarbital · Barbiturates, Plain · Pentobarbital · Secobarbital | 14 | 0 |
| N05CB | Combinations Of Barbiturates | 2 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP called?
The same molecule, Dexmedetomidine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Dormidex | Latin | Saudi Arabia |
| SOPORIDEX | Latin | Saudi Arabia |
| Naplax | Latin | Saudi Arabia |
| Demexa | Latin | Saudi Arabia |
| Dexdor | Latin | Saudi Arabia |
| DEXISUN | Latin | South Africa |
| Dexmedetomidine PSI | Latin | Saudi Arabia |
| Eccladex | Latin | South Africa |
| Precia | Latin | South Africa |
| Proxida | Latin | Saudi Arabia |
| SEDALERT | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ask about availability of DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.